Paediatric Diabetic Ketoacidosis

Author: Richard Freeman, April Donne / Editor: John Scanlon, Richard Freeman / Reviewer: Jon Bailey, Faathima Musaamil / Codes: / Published: 01/10/2014 / Reviewed: 03/09/2025

This module will explore the management of diabetic ketoacidosis in young people with relevance to the published evidence and national guidelines.

Learning Objectives:

  • Define the clinical & biochemical features of paediatric diabetic ketoacidosis
  • Understand the underlying pathophysiology
  • Identify the known risk factors
  • Commence initial management in the emergency department
  • Understand the principles that govern subsequent management
  • Identify and avoid potential complications
  • Identify and manage cases of suspected cerebral oedema

References

  1. Hanas R, Lindgren F, Lindblad B. A 2-yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use. Pediatr Diabetes. 2009;10(1):33-37.
  2. Rosilio M, Cotton JB, Wieliczko MC, et al. Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group. Diabetes Care. 1998 Jul;21(7):1146-53.
  3. Morris AD, Boyle DI, et al. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet. 1997 Nov 22;350(9090):1505-10.
  4. Rewers A, Chase HP, Mackenzie T, et al. Predictors of acute complications in children with type 1 diabetes. JAMA. 2002 May 15;287(19):2511-8.
  5. Cengiz E, Xing D, Wong JC, et al., Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D exchange clinic registry. Pediatr Diabetes. 2013;14(6):447-454.
  6. Maahs DM, Hermann JM, Holman N, et al., Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany. Diabetes Care. 2015;38(10):1876-1882. 
  7. Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child. 1999 Oct;81(4):318-23.
  8. Decourcey DD, Steil GM, Wypij D, et al., Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality. Pediatr Crit Care Med. 2013;14(7):694-700.
  9. Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med. 2001 Jan 25;344(4):264-9.
  10. Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child. 2001 Jul;85(1):16-22.
  11. Dabelea D, Rewers A, Stafford JM, et al., Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133(4):e938-e945.
  12. Komulainen J, et al. Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group. Arch Dis Child. 1996 Nov;75(5):410-5.
  13. Levy-Marchal C, Patterson CC, Green A. Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes. Diabetologia. 2001;44((suppl 3)): B75-B80.
  14. Hanas R, Lindgren F, Lindblad B. Diabetic ketoacidosis and cerebral oedema in Sweden a 2-year paediatric population study. Diabet Med. 2007;24(10):1080-1085.
  15. Rodacki M, Pereira JR, Nabuco de Oliveira AM, et al. Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes. Diabetes Res Clin Pract. 2007 Nov;78(2):259-62.
  16. Usher-Smith JA, Thompson M, Ercole A, et al., Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review. Diabetologia. 2012;55(11):2878-2894.
  17. Fritsch M, Schober E, Rami-Merhar B, et al., Diabetic ketoacidosis at diagnosis in Austrian children: a population-based analysis, 1989-2011. J Pediatr. 2013;163: 1484-8.e1.
  18. Zucchini S, Scaramuzza AE, Bonfanti R, et al., A multicenter retrospective survey regarding diabetic ketoacidosis management in Italian children with type 1 diabetes. J Diabetes Res. 2016;2016:5719470. 
  19. BSPED Interim Guideline for the Management of Children and Young People under the age of 18 years with Diabetic Ketoacidosis. British Society of Paediatric Endocrinology and Diabetes. [Accessed 10 June 2025].
  20. Dunger DB, Sperling MA, Acerini CL, et al., ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child. 2004;89(2):188-194.
  21. Sheikh-Ali M, Karon BS, Basu A, et al., Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008;31(4):643-647.
  22. Wolfsdorf JI, Glaser N, Agus M, et al., ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatric Diabetes. 2018;19:155-177.
  23. Cope JU, Morrison AE, Samuels-Reid J. Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year Food and Drug Administration retrospective study of adverse events. Pediatrics. 2008;121(5):e1133-e1138.
  24. Carlotti AP, St George-Hyslop C, Guerguerian AM, et al., Occult risk factor for the development of cerebral edema in children with diabetic ketoacidosis: possible role for stomach emptying. Pediatr Diabetes. 2009;10(8):522-533.
  25. Davids MR, Edoute Y, Stock S, et al., Severe degree of hyperglycaemia: insights from integrative physiology. QJM. 2002;95(2): 113-124.
  26. Malone JI, Brodsky SJ. The value of electrocardiogram monitoring in diabetic ketoacidosis. Diabetes Care. 1980;3(4):543-547.
  27. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet1974;2(7872):81-4.
  28. Leach D, Barton J. Paediatric DKA Protocol Generator. 2021 [Accessed 7 June 2025].
  29. Tattersall RB. A paper which changed clinical practice (slowly). Jacob Holler on potassium deficiency in diabetic acidosis (1946). Diabet Med 1999;16(12):97884.
  30. Atchley D, Loeb R, Richards D Jr, Benedict E, et al., On diabetic ketoacidosis: a detailed study of electrolyte balances following the withdrawal and reestablishment of insulin therapy. J Clin Invest. 1933;12:297-326.
  31. Nabarro J, Spencer A, Stowers J. Metabolic studies in severe diabetic ketosis. Q J Med. 1952;82:225-248. 
  32. Danowski T, Peters J, Rathbun J, et al., Studies in diabetic acidosis and coma, with particular emphasis on the retention of administered potassium. J Clin Invest. 1949;28:1-9. 
  33. Darrow D, Pratt E. Retention of water and electrolyte during recovery in a patient with diabetic acidosis. J Pediatr. 1952;41:688-696.
  34. Edge JA, Jakes RW, Roy Y, et al., The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia. 2006;49(9):2002-2009. 
  35. Hoorn EJ, Carlotti AP, Costa LA, et al., Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis. J Pediatr. 2007; 150(5):467-473.
  36. Van der Meulen JA, Klip A, Grinstein S. Possible mechanism for cerebral oedema in diabetic ketoacidosis. Lancet. 1987;2(8554):306-308. 
  37. Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. Br Med J (Clin Res Ed). 1984; 289(6451):1035-1038. 
  38. Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med. 1986;105(6):836-840.
  39. Okuda Y, Adrogue HJ, Field JB, et al., Counterproductive effects of sodium bicarbonate in diabetic ketoacidosis. J Clin Endocrinol Metab. 1996;81(1):314-320.
  40. Green SM, Rothrock SG, Ho JD, et al., Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis. Ann Emerg Med. 1998;31(1):41-48.
  41. Assal JP, Aoki TT, Manzano FM, et al., Metabolic effects of sodium bicarbonate in management of diabetic ketoacidosis. Diabetes. 1974;23(5):405-411.
  42. Ohman JL Jr, Marliss EB, Aoki TT, et al., The cerebrospinal fluid in diabetic ketoacidosis. N Engl J Med. 1971;284(6):283-290. 
  43. Lever E, Jaspan JB. Sodium bicarbonate therapy in severe diabetic ketoacidosis. Am J Med. 1983;75(2):263-268.
  44. Palmer BF, Clegg DJ. Electrolyte and acid-base disturbances in patients with diabetes mellitus. N Engl J Med. 2015;373(6):548-559.
  45. Keller U, Berger W. Prevention of hypophosphatemia by phosphate infusion during treatment of diabetic ketoacidosis and hyperosmolar coma. Diabetes. 1980;29(2):87-95.
  46. Wilson HK, Keuer SP, Lea AS, et al., Phosphate therapy in diabetic ketoacidosis. Arch Intern Med. 1982;142(3): 517-520.
  47. Becker DJ, Brown DR, Steranka BH, et al. Phosphate replacement during treatment of diabetic ketosis. Effects on calcium and phosphorus homeostasis. Am J Dis Child. 1983;137(3):241-246.
  48. Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab. 1983; 57(1):177-180.
  49. Clerbaux T, Reynaert M, Willems E, et al., Effect of phosphate on oxygen-hemoglobin affinity, diphosphoglycerate and blood gases during recovery from diabetic ketoacidosis. Intensive Care Med. 1989;15(8):495-498. 
  50. Harris GD, Fiordalisi I. Physiologic management of diabetic ketoacidemia. A 5-year prospective pediatric experience in 231 episodes. Arch Pediatr Adolesc Med. 1994;148(10):1046-1052.
  51. Glaser NS, Marcin JP, Wootton-Gorges SL, et al., Correlation of clinical and biochemical findings with diabetic ketoacidosis-related cerebral edema in children using magnetic resonance diffusion-weighted imaging. J Pediatr. 2008;153(4):541-546.

Further reading:

Leave a Reply